Medtronic plc
General ticker "MDT" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $113.7B (TTM average)
Medtronic plc follows the US Stock Market performance with the rate: 54.2%.
Estimated limits based on current volatility of 1.0%: low 101.61$, high 103.69$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends (quarterly): last record date 2025-09-26, amount 0.71$ (Y2.78%)
- Total employees count: 92000 as of 2015
- Top business risk factors: Market competition, Regulatory and compliance, Supply chain disruptions, Liquidity and credit risks, Acquisition/divestiture risks
- Price in estimated range
- Earnings for 6 months up through Q2 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-04-30 to 2027-04-30
- 2025-04-30 to 2026-04-30 estimated range: [75.67$, 104.24$]
- 2026-04-30 to 2027-04-30 estimated range: [80.09$, 109.94$]
Financial Metrics affecting the MDT estimates:
- Negative: with PPE of 15.2 at the end of fiscal year the price was very high
- Positive: 7.86 < Operating profit margin, % of 17.76
- Positive: 41.86 < Shareholder equity ratio, % of 52.38 <= 63.39
- Negative: negative Industry operating cash flow (median)
- Positive: Inventory ratio change, % of 0.15 <= 0.84
- Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 4.84
- Positive: Industry inventory ratio change (median), % of -0.67 <= -0.15
- Positive: Interest expense per share per price, % of 0.68 <= 0.79
- Negative: Operating cash flow per share per price, % of 6.53 <= 6.82
Short-term MDT quotes
Long-term MDT plot with estimates
Financial data
| YTD | 2023-04-30 | 2024-04-30 | 2025-04-30 |
|---|---|---|---|
| Operating Revenue | $31,227.00MM | $32,364.00MM | $33,537.00MM |
| Operating Expenses | $25,742.00MM | $27,220.00MM | $27,582.00MM |
| Operating Income | $5,485.00MM | $5,144.00MM | $5,955.00MM |
| Non-Operating Income | $-121.00MM | $-307.00MM | $-327.00MM |
| Interest Expense | $636.00MM | $719.00MM | $729.00MM |
| R&D Expense | $2,696.00MM | $2,735.00MM | $2,732.00MM |
| Income(Loss) | $5,364.00MM | $4,837.00MM | $5,628.00MM |
| Taxes | $1,580.00MM | $1,133.00MM | $936.00MM |
| Profit(Loss)* | $3,758.00MM | $3,676.00MM | $4,662.00MM |
| Stockholders Equity | $51,483.00MM | $50,214.00MM | $48,024.00MM |
| Inventory | $5,293.00MM | $5,217.00MM | $5,476.00MM |
| Assets | $90,948.00MM | $89,981.00MM | $91,680.00MM |
| Operating Cash Flow | $6,039.00MM | $6,787.00MM | $7,044.00MM |
| Capital expenditure | $1,459.00MM | $1,587.00MM | $1,859.00MM |
| Investing Cash Flow | $-3,493.00MM | $-2,366.00MM | $-1,937.00MM |
| Financing Cash Flow | $-4,960.00MM | $-4,450.00MM | $-4,361.00MM |
| Earnings Per Share** | $2.83 | $2.77 | $3.63 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.